Screener
Alnylam Pharmaceuticals ALNY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's free cash flow?
- Alnylam Pharmaceuticals (ALNY) reported free cash flow of $292.04M in Q2 2026.
- How has Alnylam Pharmaceuticals's free cash flow changed year-over-year?
- Alnylam Pharmaceuticals's free cash flow increased by 109.4% year-over-year, from $139.44M to $292.04M.
- What is the long-term trend for Alnylam Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2025), Alnylam Pharmaceuticals's free cash flow has grown at a -13.5% compound annual growth rate (CAGR), from -$718.07M to $465.38M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Alnylam Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude